The ACMG has issued a policy statement recommending Fragile X testing for "women with reproductive or fertility problems associated with elevated FSH levels, especially if there is a family history of premature ovarian failure, Fragile X syndrome, or undiagnosed mental retardation" (Monaghan et al., 2013; Sherman et al., 2005). This evidence concerns the gene BRD2 and primary ovarian failure.